Pronounced palatal and mandibular tori observed in a patient with chronic phenytoin therapy: A case report

Journal of Periodontology

Volumn 70, Issue 4, 1999, Pages 445-448

  Sasaki, Hideki ^a   Ikedo, Dai ^b   Kataoka, Masatoshi ^b   Kido, Jun Ichi ^b   Kitamura, Seiichiro ^c   Nagata, Toshihiko ^b  

^a Sasaki Dental Clinic   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c NONE

Author keywords

Osteogenesis; Phenytoin adverse effects; Torus mandibular; Torus palatal

Indexed keywords

PHENYTOIN;

ADULT; ANTICONVULSANT THERAPY; ARTICLE; BONE DEVELOPMENT; CASE REPORT; EXOSTOSIS; HARD PALATE; HUMAN; MALE; MANDIBLE; SEIZURE;

ANTICONVULSANTS; EXOSTOSES; HUMANS; MALE; MANDIBULAR DISEASES; MIDDLE AGED; PALATE; PHENYTOIN;

EID: 0032939136     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.1999.70.4.445     Document Type: Article

References (28)

1. Kimball OP. The treatment of epilepsy with sodium diphenylhydantoinate. JAMA 1939; 112:1244-1245.
2. Hassel TM. Phenytoin: Gingival overgrowth. In: Hassel TM, ed. Epilepsy and the Oral Manifestations of Phenytoin Therapy, Basel: S. Karger; 1981:116-202.
3. Kattan KR. Calvarial thickening after dilantin medication. Am J Roentogenol Radium Ther Nucl Med 1970;110:102-106.
4. Lefebvre EB, Haining RG, Labbe RF. Coarse facies, calvarial thickening and hyperphosphatasia associated with long-term anticonvulsant therapy. N Engl J Med 1972;286:1301-1302.
5. Johnson JP. Acquired craniofacial features associated with chronic phenytoin therapy. Clin Pediatrics 1984;23:671-674.
6. Christiansen C, Rodbro P, Lund M. Incidence of anticonvulsant osteomalacia and effect of vitamin D: controlled therapeutic trial. Br Med J 1973;4:695-698.
7. Koch H-U, Kraft D, Von Herrath D, Schaefer K. Influence of diphenylhydantoin and phenobarbital on intestinal calcium transport in the rat. Epilepsia 1972;13:829-834.
8. Ohta T, Wergedal JE, Gruber HE, Baylink DJ, Lau K-H W. Low dose phenytoin is an osteogenic agent in the rat. Calcif Tissue Int 1995;56:42-48.
9. Ohta T, Wergedal JE, Matsuyama T, Baylink DJ, Lau K-H W. Phenytoin and fluoride act in concert to stimulate bone formation and to increase bone volume in adult male rats. Calcif Tissue Int 1995;56:390-397.
10. Lau K-H W, Nakade O, Barr B, Taylor AK, Houchin K, Baylink DJ. Phenytoin increases markers of osteogenesis for the human species in vitro and in vivo. J Clin Endocrinol Metab 1995;80:2347-2353.
11. Nakade O, Baylink DJ, Lau K-H W. Phenytoin at micromolar concentrations is an osteogenic agent for human-mandible-derived bone cells in vitro. J Dent Res 1995;74:331-337.
12. Sassouni V. Treatment of oral nonmalignant tumors and lesions. In: Archer WH, ed. Oral and Maxillofacial Surgery, 5th ed. Philadelphia: WB Saunders Company;1975:709-716.
13. Seah YH. Torus palatinus and mandibularis: a review of the literature. Aust Dent J 1995;40:318-321.
14. Reichart PA, Neuhaus F, Sookasem M. Prevalence of torus palatinus and torus mandibularis in Germans and Thai. Commun Dent Oral Epidemiol 1988;16:61-64.
15. Gorsky M, Raviv M, Kfir E, Moskona D. Prevalence of torus palatinus in a population of young and adult Israelis. Arch Oral Biol 1996; 41:623-625.
16. Hugen LK. Palatine and mandibular tori. A morphologic study in the current Norwegian population. Acta Odontol Scand 1992;50, 65-77.
17. Shah DS, Sanghavi SJ, Chawda JD, Shah RM. Prevalence of torus palatinus and torus mandibularis in 1000 patients. Indian J Dent Res 1992;3:107-110.
18. Bouquot JE, Gundlach KKH. Oral exophytic lesions in 23,616 white Americans over 35 years of age. Oral Surg Oral Med Oral Pathol 1986; 62:284-291.
19. Eggen S, Natvig B. Varidation in torus mandibularis prevalence in Norway. A statistical analysis using logistic regression. Commun Dent Oral Epidemiol 1991;19:32-35.
20. Suzuki M, Kasai T. A familial study of torus palatinous and torus mandibularis. Am J Phys Anthrop 1960;18:264-272.
21. King DR, Moore GE. The prevalence of torus palatinus. J Oral Med 1971;26:113-115.
22. King DR, Moore GE. An analysis of torus palatinus in a transatlantic study. J Oral Med 1976;31:44-46.
23. Eggen S. Correlated characteristics of the jaws: association between torus mandibularis and marginal alveolar bone height. Acta Odontol Scand 1992;50:1-6.
24. Ohno N, Sakai T, Mizutani T. Prevalence of torus palatinus and torus mandibularis in five Asian populations. Aichi-Gakuin Dent Sci 1988;1:1-8.
25. Sakai T. Anthroposcopic observations of palatine and mandibular tori in Japanese (in Japanese). Shinshu Med J 1954;3:303-307.
26. Vernillo AT, Schwartz NB. The effects of phenytoin (5,5-diphenylhydantoin) on human gingival fibroblasts in culture. J Periodont Res 1987;22:307-312.
27. Ebadi MS, Scott PM. Increase in collagen level by diphenylhydantoin as possible mechanism of drug-induced gingival hyperplasia. Clin Toxicol 1971;4:39-46.
28. Hassel TM. Phenytoin: chemistry, disposition and metabolism. In: Hassel TM, ed. Epilepsy and the Oral Manifestations of Phenytoin Therapy. Basel: S. Karger;1981:60-69.